Keyphrases
Phosphorylation
100%
Epidermal Growth Factor Receptor
100%
Cisplatin
100%
Tyrosine Kinase
100%
Lung Cancer Cells
100%
Kinase-independent
100%
Activating mutation
100%
Cisplatin Treatment
33%
Cancer Progression
16%
Cancer Cell Death
16%
Cell Apoptosis
16%
Non-canonical Pathway
16%
Non-canonical
16%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
16%
Threonine
16%
Receptor Phosphorylation
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Receptor Activation
16%
ERK MAPK
16%
Epidermal Growth Factor Receptor Signaling
16%
Survival Pathways
16%
Tyrosine Residue
16%
EGFR mutation
16%
Resistance Mechanisms
16%
Internalization Mechanism
16%
Combinational Therapy
16%
Cancer Resistance
16%
Exon 19 Deletion
16%
Resistance to Anticancer Therapy
16%
Cancer Hallmarks
16%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Epidermal Growth Factor Receptor
100%
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Cisplatin
100%
Mitogen-Activated Protein Kinase
25%
Wild Type
12%
Cell Death
12%
Tyrosine
12%
Exon
12%
Anticancer
12%
Internalization
12%
Serine
12%
Threonine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Cancer
100%
Cisplatin
100%
Protein Tyrosine Kinase
100%
Malignant Neoplasm
12%
Cancer Growth
12%
Threonine
12%
Non Small Cell Lung Cancer
12%
Serine
12%
Cancer Resistance
12%